1. PHILHEALTH CLINICAL PATHWAYS CLINICAL GUIDELINES

2. DENGUE CLINICAL PATHWAY

3. 1 st 30 min2 nd 30 min3 rd 30 min AssessmentAscertained with fever of 2-7 days duration with any of the following:  skin flushing  rashes  headache  retro-orbital pain  myalgia/arthralgia, Risk factors for hemorrhagic tendency assessed. DiagnosticsCBC takenPlatelet ct less than 100,000, do PTT and blood typing TreatmentsPlatelet ct greater than 100,000 discharge and advised to do serial CBC daily Admit if:  platelet count is less than 100,000 OR if with any of the ff. regardless of the platelet count  spontaneous bleeding  persistent abdominal pain  persistent vomiting  changes in mental status  restlessness  weak rapid pulse  cold clammy skin  circumoral cyanosis  difficulty of breathing  seizures  hypotension  narrowing of pulse pressure. TeachingGive information on Dengue fever and measures to control infection at home

4. ADMITTING ORDERS Admitting Impression: Dengue Fever Concomitant diagnosis:____________________________ Please admit to room of choice under the service of Dr. ________________ Diet: __________________________________ Vital signs: every 4 hours every _____________ Lab: – CBC – blood typing – PTT – SGPT – Urinalysis – Chest x-ray PA and lateral – Na, K – BUN, Creatinine – Others: __________________________ __________________________

5. ADMITTING ORDERS IVF: __________________________ Other medications: _________________________________________________ Ancillary Therapy: _________________________________________________ Referral to other services: Hematology _________________________________________________ Others _________________________________________________ Inform attending physician(s) and resident-on-duty of patient’s room number Refer for any undue development. ______________________ Signature over printed name Attending Physician